Weil Company’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.37M | Buy |
9,679
+1
| +0% | +$233 | 0.53% | 45 |
|
|
2025
Q4 | $2M | Buy |
9,678
+1
| +0% | +$198 | 0.46% | 50 |
|
|
2025
Q3 | $1.79M | Sell |
9,677
-35
| -0.4% | -$6K | 0.43% | 53 |
|
|
2025
Q2 | $1.48M | Buy |
9,712
+9
| +0.1% | +$1.38K | 0.39% | 55 |
|
|
2025
Q1 | $1.61M | Sell |
9,703
-71
| -0.7% | -$11.1K | 0.48% | 41 |
|
|
2024
Q4 | $1.41M | Sell |
9,774
-112
| -1% | -$17.4K | 0.49% | 43 |
|
|
2024
Q3 | $1.6M | Buy |
9,886
+2
| +0% | +$319 | 0.53% | 49 |
|
|
2024
Q2 | $1.44M | Sell |
9,884
-389
| -4% | -$57.9K | 0.53% | 43 |
|
|
2024
Q1 | $1.63M | Sell |
10,273
-391
| -4% | -$62.2K | 0.64% | 42 |
|
|
2023
Q4 | $1.67M | Sell |
10,664
-1,336
| -11% | -$205K | 0.73% | 35 |
|
|
2023
Q3 | $1.87M | Sell |
12,000
-2,318
| -16% | -$382K | 0.93% | 33 |
|
|
2023
Q2 | $2.37M | Sell |
14,318
-1,653
| -10% | -$267K | 1.06% | 27 |
|
|
2023
Q1 | $2.48M | Sell |
15,971
-106
| -0.7% | -$17.1K | 1.12% | 26 |
|
|
2022
Q4 | $2.84M | Sell |
16,077
-209
| -1% | -$36.1K | 1.29% | 17 |
|
|
2022
Q3 | $2.66M | Buy |
16,286
+423
| +3% | +$71.6K | 1.63% | 14 |
|
|
2022
Q2 | $2.82M | Sell |
15,863
-296
| -2% | -$52.7K | 1.58% | 13 |
|
|
2022
Q1 | $2.86M | Buy |
16,159
+389
| +2% | +$66.2K | 1.44% | 17 |
|
|
2021
Q4 | $2.7M | Sell |
15,770
-1,799
| -10% | -$295K | 1.26% | 19 |
|
|
2021
Q3 | $2.84M | Sell |
17,569
-54
| -0.3% | -$9.21K | 1.48% | 17 |
|
|
2021
Q2 | $2.9M | Buy |
17,623
+1,936
| +12% | +$321K | 1.47% | 15 |
|
|
2021
Q1 | $2.58M | Buy |
15,687
+629
| +4% | +$102K | 1.46% | 17 |
|
|
2020
Q4 | $2.37M | Buy |
15,058
+248
| +2% | +$36.6K | 1.42% | 17 |
|
|
2020
Q3 | $2.21M | Buy |
14,810
+1,148
| +8% | +$170K | 1.61% | 18 |
|
|
2020
Q2 | $1.92M | Buy |
13,662
+947
| +7% | +$138K | 1.62% | 19 |
|
|
2020
Q1 | $1.67M | Buy |
12,715
+514
| +4% | +$72.9K | 1.57% | 19 |
|
|
2019
Q4 | $1.78M | Sell |
12,201
-23
| -0.2% | -$3.12K | 1.36% | 20 |
|
|
2019
Q3 | $1.58M | Buy |
12,224
+18
| +0.1% | +$2.37K | 1.17% | 19 |
|
|
2019
Q2 | $1.7M | Buy |
12,206
+466
| +4% | +$64.5K | 1.38% | 19 |
|
|
2019
Q1 | $1.64M | Sell |
11,740
-184
| -2% | -$24.6K | 1.37% | 19 |
|
|
2018
Q4 | $1.54M | Buy |
11,924
+85
| +0.7% | +$11.9K | 1.39% | 20 |
|
|
2018
Q3 | $1.64M | Sell |
11,839
-179
| -1% | -$23.8K | 1.35% | 23 |
|
|
2018
Q2 | $1.46M | Buy |
12,018
+261
| +2% | +$32.6K | 1.23% | 23 |
|
|
2018
Q1 | $1.51M | Sell |
11,757
-512
| -4% | -$69.2K | 1.41% | 21 |
|
|
2017
Q4 | $1.71M | Buy |
+12,269
| New | +$1.71M | 1.57% | 19 |
|
Other funds holding JNJ
VCM
VPM
Weil Company's JNJ Position: Q1 2026 in Review
Weil Company increased its Johnson & Johnson (JNJ) stake by 0.01% in Q1 2026, buying an estimated $233 and bringing the position to 9,679 shares worth $2.37M. The position accounts for 0.53% of the portfolio, ranked #45.
Weil Company first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.9M in Q2 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Weil Company held 9,679 shares of Johnson & Johnson worth $2.37M as of Q1 2026.
- Weil Company bought 1 Johnson & Johnson share in Q1 2026, an estimated $233.
- Johnson & Johnson made up 0.53% of Weil Company's portfolio in Q1 2026, its #45 holding.
- Weil Company first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- Weil Company's Johnson & Johnson position peaked at $2.9M in Q2 2021.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Weil Company's 13F filing for Q1 2026, filed 15 Apr 2026.